Avantor (NYSE:AVTR) Releases FY 2024 Earnings Guidance

Avantor (NYSE:AVTR) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.960-1.040 for the period, compared to the consensus earnings per share estimate of 1.000. The company issued revenue guidance of -.

Avantor Stock Performance

Shares of NYSE AVTR traded down $0.26 during midday trading on Wednesday, reaching $27.39. 2,903,172 shares of the company were exchanged, compared to its average volume of 6,965,714. The stock has a market cap of $18.62 billion, a P/E ratio of 70.90, a PEG ratio of 2.70 and a beta of 1.32. Avantor has a 1 year low of $16.63 and a 1 year high of $27.99. The stock has a fifty day simple moving average of $22.47 and a 200 day simple moving average of $23.71. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.94.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on AVTR. Deutsche Bank Aktiengesellschaft boosted their target price on Avantor from $23.00 to $25.00 and gave the company a hold rating in a report on Thursday, April 18th. Morgan Stanley upped their price objective on shares of Avantor from $28.00 to $29.00 and gave the stock an overweight rating in a research report on Monday. Robert W. Baird boosted their price target on shares of Avantor from $26.00 to $27.00 and gave the stock an outperform rating in a research note on Monday. Barclays increased their price target on shares of Avantor from $25.00 to $28.00 and gave the stock an overweight rating in a report on Monday. Finally, Stifel Nicolaus lifted their price objective on Avantor from $27.00 to $28.00 and gave the company a buy rating in a report on Monday. Five investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Avantor presently has a consensus rating of Moderate Buy and a consensus price target of $27.21.

Insider Buying and Selling at Avantor

In other news, insider Christophe Couturier 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.50% of the stock is owned by corporate insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.